NSPR (inspiremd.com) צמיחת רווח למניה השנה

InspireMD, Inc. (NSPR) is establishing a standard for vascular protection through its MicroNet technology to prevent strokes. Annual EPS growth illustrates the market response to these achievements, with the metric holding around 20.70. The business relies on global sales across Asia and Europe to mitigate risks. High surgeon confidence in the C-Guard system ensures stable loyalty from the global community for the brand.

InspireMD, Inc. (NSPR) generates revenue through the sale of its stents, yet the volatility of expansion costs directly impacts annual EPS growth. This indicator measures the dynamics of net income per share relative to the same period last year. The calculation captures the percentage deviation of the current result from the baseline value. A stable plateau in annual EPS growth signals business consolidation. It is critical for investors to monitor the exit from this lull to assess capital risks.